London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
You will only have one login account. Registering with multiple accounts is not allowed. Any user found to have more than one account on this site will have all, and any future accounts suspended permanently.
Your email and password must only be used by you. If a post is made under your account, it will be considered that it was posted by yourself.
Your account nickname must not be the same, or contain, listed company names or board members' names.
While debating and discussion is fine, we will not tolerate; rudeness, swearing, insulting posts, personal attacks, or posts which are invasive of another's privacy.
You will not;
discuss illegal or criminal activities.
post any confidential or price sensitive information or that is not public knowledge.
post misleading or false statements regarding the share price and performance. Such posts are deemed as market abuse, and may be reported to the appropriate authorities.
post any private communication, or part thereof, from any other person, including from a member of the board of directors of a listed company. Such posts cannot be verified as true and could be deemed to be misleading.
post any personal details (e.g. email address or phone number).
post live price or level 2 updates.
publish content that is not your original work, or infringes the copyright or other rights of any third party.
post non-constructive, meaningless, one word (or short) non-sense posts.
post links to, or otherwise publish any content containing any form of advertising, promotion for goods and services, spam, or other unsolicited communication.
post any affiliate or referral links, or post anything asking for a referral.
post or otherwise publish any content unrelated to the board or the board's topic.
re-post premium share chat posts on regular share chat.
restrict or inhibit any other user from using the boards.
impersonate any person or entity, including any of our employees or representatives.
post or transmit any content that contains software viruses, files or code designed to interrupt, destroy or limit the functionality of this website or any computer software or equipment.
If you are going to post non-English, please also post an English translation of your post.
If you are going to post non-English, please also post an English translation of your post.
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium and Verified Members
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Rocquet aka Goldtrig, you are one complex individual. Total tunnel vision, basically when your right, your right, and when your wrong, you right.. all in your own mind. It's your way or no way. .....p.s why did you change your username from Goldtrig to Rocquet ? You almost sound bipolar , harmless but odd.
"Think about this, if ODX are manufacturing the best test in the world then it will put them on the whole map on the world!"
Dude, that's not how business works. It's my belief that if they get the approvals they are currently seeking ODX will be maxed out producing and selling at higher margin their own Visitect test. And there are by now very many 'best in world' tests out there so take it with a pinch of salt and don't believe everything the pumpers and single stock fanatics on these bulletin boards say.
"Hello EU. Please forgive and forget the 10 years of acrimony during brexit and the fact that we couldn't wait to leave the EU. That was nothing to do with us Mon cheri. We'd like to sell you our antigen test for home use"
Isn't that the british made test that failed validation by the british government, whilst 25 other tests were approved, including a number of chinese "crap" tests ?". Why the hell would we want to buy something from outside the EU that even their own government failed "
"Yeah, that's what i thought, we'll stick to the Roche that's made in Europe and the extremely popular Abbot test that's been CE-ed for europe since the beginning of the year for self-swabbing and asymptomatic testing. Both those tests were also passed by Porton down. Thanks for your call"
Rocquet, that's a link to Avacta's website. Not an independent evaluation. I don't care whose test it is we make. One of Avacta's recent RNS's suggested they weren't even bothering with UK evaluation and were focused overseas. Have you got a link to show they are going for UK evaluation?
rocquet it is the best performing test in a small study from 1 site. This means that the data is very likely to be affected by bias. If you showed me a triple centre study/ group of independent studies with sensitivity as high as shown in the initial data i would concede that yes it is by far and away the best test. I also dislike that the name of the trial partner is not shared. Why would that info be withheld?
I don't know why it isn't Surescreen to be fair - they've obviously passed everything and are busy making tests, so in this emergency why aren't we just building their product? I've genuinely been stumped by this since they started manufacturing, and thought we were waiting for a next-gen better model to use after PD finally completed.
I think it could be Surescreen. They are also part of the UK RTC. Doesn't look like the DHSC will fall on their sword. They will be forced to explain why they have approved a test with 78% sensitivity from Innova and not yet approved a test with between 94 and 98% sensitivity depending on ct values. Can't say I am not totally fed up with the UK authorities. Looks like MHRA were pressured into agreeing Innova due to their capacity. What a mess.
rocquet i have never seen anybody so confident about a products performance based upon a small study. As mentioned by others if AVCT is chosen it sets ODX back by months so id rather they crack on with the Visitect product elsewhere especially as it seems our own government wont do anything without their palms being greased.
"Also RNS states CE marking for home use is being sought is that for UK or EU home use?"
The first line of the RNS of 8 June is fairly clear:
"Omega announces that it has begun the process of engagement with its European Notified Body seeking CE marking of the VISITECT® COVID-19 Antigen test, a rapid point-of-care diagnostic test for the detection of active COVID-19 infections as a self-test."
"We just make tests and we don't and shouldn't care whose test we make!"
Do you seriously believe that?!!
In case you didn't know Visitect is ODX's own brand. Yes the antigen test is developed by Mologic but IMO still likely to be much higher margin for ODX than if they are ordered to produce an AVCT or other third party test. Also it sounds like ODX are ready to start churning out Visitect thereby avoiding the several months technology transfer delay likely required to produce a new third party test.
As to the unshakable belief of some AVCT followers that their test is world beating, the recent SP reaction tells its own story. For what it's worth, Visitect is also described as best in class and that claim is based on a very thorough evaluation.
Doesn't the test need to go through porton down for home use in the UK? Happy to be corrected if Ive misunderstood this! That being the case I thought Avacta would encounter difficulties due to frozen samples being used?
Also RNS states CE marking for home use is being sought is that for UK or EU home use?
Rocquet, I was just commenting that Avacta isn't on the list published today. ODX would be mad to be planning to manufacture a test that has yet to get approval considering the mologic saga. Do you have some links for any Avacta evaluations already preformed?
This is not an Avacta ramp but research to figure out what test ODX might manufacture.
This is referring to the gov contract but it seems for some reason the gov have taken a step back. I assume they would still facilitate the licence but this does read more like omega are trying to figure out a test that will work for them, for the gov and the company with the IP. A bit of a change as for some reason it now looks like ODX have an input to the test selection but from a very limited list. Is this due to the amount of time the gov have wasted and trying to let ODX choose the one that suits them best? I suspect we don't really want to do Surescreen in order to provide a risk reduction by having 2 tests.